Robert A. Berman's most recent trade in Cullen Frost Bankers Inc. was a trade of 2,007 Common Stock, $0.01 par value done . Disclosure was reported to the exchange on Feb. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 2,007 | 28,820 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Sale or transfer of securities back to the company at price $ 141.08 per share. | 06 Feb 2025 | 537 | 28,283 (0%) | 0% | 141.1 | 75,760 | Common Stock, $0.01 par value |
| enVVeno Medical Corporation | Robert Berman A. | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 19 Dec 2024 | 12,000 | 222,236 (1%) | 0% | 2.6 | 30,600 | Common Stock |
| Rekor Systems Inc | Berman A. Robert | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Dec 2024 | 864,104 | 1,001,000 (4%) | 3% | - | Common Stock | |
| enVVeno Medical Corporation | Robert Berman A. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2024 | 200,000 | 200,000 | - | - | Stock Options | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Sale of securities on an exchange or to another person at price $ 126.31 per share. | 01 Nov 2024 | 3,506 | 26,661 (0%) | 0% | 126.3 | 442,843 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2024 | 2,803 | 2,803 | - | - | Restricted Stock Units | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Oct 2024 | 1,880 | 30,639 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Oct 2024 | 1,880 | 0 | - | - | Restricted Stock Units | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Oct 2024 | 1,247 | 29,062 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Oct 2024 | 1,247 | 0 | - | - | Restricted Stock Units | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.42 per share. | 26 Oct 2024 | 472 | 30,167 (0%) | 0% | 127.4 | 60,142 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.42 per share. | 26 Oct 2024 | 303 | 28,759 (0%) | 0% | 127.4 | 38,608 | Common Stock, $0.01 par value |
| Rekor Systems Inc | Robert A. Berman | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2024 | 300,000 | 1,685,219 (7%) | 1% | 0 | Common Stock | |
| Rekor Systems Inc | Robert A. Berman | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Jun 2024 | 1,000,000 | 1,000,000 | - | - | Warrants (right to buy) | |
| Rekor Systems Inc | Robert A. Berman | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Jun 2024 | 1,000,000 | 0 | - | - | Warrants (right to buy) | |
| Rekor Systems Inc | Robert A. Berman | Director, Executive Chairman | 18 Jun 2024 | 700,000 | 0 | - | - | Warrants (right to buy) | ||
| Rekor Systems Inc | Robert A. Berman | Director, Executive Chairman | 18 Jun 2024 | 700,000 | 1,865,104 (8%) | 3% | 1.4 | 980,000 | Common Stock | |
| Rekor Systems Inc | Robert A. Berman | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1.56 per share. | 21 May 2024 | 10,000 | 1,385,219 (6%) | 0% | 1.6 | 15,557 | Common Stock |
| Rekor Systems Inc | Robert A. Berman | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1.65 per share. | 20 May 2024 | 20,000 | 1,375,219 (6%) | 0% | 1.7 | 33,062 | Common Stock |
| Rekor Systems Inc | Robert A. Berman | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1.34 per share. | 17 May 2024 | 100,000 | 1,355,219 (6%) | 0% | 1.3 | 133,520 | Common Stock |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Sale of securities on an exchange or to another person at price $ 105.49 per share. | 14 Mar 2024 | 1,312 | 27,815 (0%) | 0% | 105.5 | 138,403 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 2,159 | 29,974 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Sale or transfer of securities back to the company at price $ 114.03 per share. | 05 Mar 2024 | 847 | 29,127 (0%) | 0% | 114.0 | 96,583 | Common Stock, $0.01 par value |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Other type of transaction at price $ 2.50 per share. | 04 Mar 2024 | 120,000 | 1,255,219 (5%) | 0% | 2.5 | 300,000 | Common Stock |
| enVVeno Medical Corporation | Robert Berman A. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2023 | 300,000 | 300,000 | - | - | Stock Options | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2023 | 1,330 | 0 | - | - | Restricted Stock Units | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2023 | 1,330 | 27,992 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.67 per share. | 29 Oct 2023 | 323 | 27,669 (0%) | 0% | 89.7 | 28,963 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2023 | 2,741 | 2,741 | - | - | Restricted Stock Units | |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.45 per share. | 25 Aug 2023 | 10,000 | 1,135,219 (5%) | 0% | 3.4 | 34,455 | Common Stock |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 50,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 18 Aug 2023 | 50,000 | 1,125,219 (5%) | 0% | 1 | 50,000 | Common Stock |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 18 Aug 2023 | 50,000 | 1,075,219 (4%) | 0% | 1.5 | 75,000 | Common Stock |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 50,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.14 per share. | 18 Aug 2023 | 25,000 | 1,025,219 (4%) | 0% | 3.1 | 78,425 | Common Stock |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Jun 2023 | 1,000,000 | 1,165,104 (5%) | 4% | - | Common Stock | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Purchase of securities on an exchange or from another person at price $ 95.25 per share. | 04 May 2023 | 1,500 | 26,662 (0%) | 0% | 95.3 | 142,875 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 1,327 | 25,485 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.72 per share. | 07 Mar 2023 | 323 | 25,162 (0%) | 0% | 127.7 | 41,254 | Common Stock, $0.01 par value |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Jan 2023 | 1,000,000 | 1,000,000 | - | - | Warrats (right to buy) | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2022 | 350 | 24,239 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2022 | 175 | 24,064 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Sale of securities on an exchange or to another person at price $ 151.62 per share. | 28 Oct 2022 | 1,941 | 24,589 (0%) | 0% | 151.6 | 294,294 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2022 | 1,573 | 1,573 | - | - | Restricted Stock Units | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2022 | 1,292 | 26,844 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2022 | 1,292 | 0 | - | - | Restricted Stock Units | |
| Cullen Frost Bankers Inc. | Robert A. Berman | GEVP Research & Strategy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.08 per share. | 23 Oct 2022 | 314 | 26,530 (0%) | 0% | 142.1 | 44,613 | Common Stock, $0.01 par value |
| enVVeno Medical Corporation | Robert A. Berman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.80 per share. | 27 Jun 2022 | 2,500 | 210,236 (1%) | 0% | 3.8 | 9,500 | Common Stock |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 1,272 | 25,831 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 133.54 per share. | 08 Mar 2022 | 309 | 25,552 (0%) | 0% | 133.5 | 41,264 | Common Stock, $0.01 par value |
| enVVeno Medical Corporation | Robert A. Berman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 349,781 | 349,781 | - | - | Stock Options | |
| enVVeno Medical Corporation | Robert A. Berman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 200,000 | 207,736 (1%) | 1% | - | Common Stock | |
| enVVeno Medical Corporation | Robert A. Berman | Director, CEO | Purchase of securities on an exchange or from another person at price $ 7.43 per share. | 19 Nov 2021 | 2,000 | 7,736 (0%) | 0% | 7.4 | 14,860 | Common Stock |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.13 per share. | 17 Nov 2021 | 75,000 | 1,000,219 (4%) | 0% | 7.1 | 534,750 | Common Stock |
| enVVeno Medical Corporation | Robert A. Berman | CEO | Purchase of securities on an exchange or from another person at price $ 7.87 per share. | 16 Nov 2021 | 2,000 | 5,736 (0%) | 0% | 7.9 | 15,740 | Common Stock |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Sale of securities on an exchange or to another person at price $ 136.54 per share. | 02 Nov 2021 | 2,518 | 24,499 (0%) | 0% | 136.5 | 343,808 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2021 | 1,247 | 1,247 | - | - | Restricted Stock Units | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2021 | 1,213 | 27,312 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2021 | 1,213 | 0 | - | - | Restricted Stock Units | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. | 24 Oct 2021 | 295 | 27,017 (0%) | 0% | 131.3 | 38,736 | Common Stock, $0.01 par value |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 15 Sep 2021 | 2,725,836 | 0 (0%) | 12% | - | Common Stock | |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 15 Sep 2021 | 849,999 | 925,219 (4%) | 3% | - | Common Stock | |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Sep 2021 | 775,000 | 2,165,104 (9%) | 3% | - | Common Stock | |
| enVVeno Medical Corporation | Robert A. Berman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.47 per share. | 18 May 2021 | 3,000 | 3,736 (0%) | 0% | 5.5 | 16,410 | Common Stock, $0.00001 par value |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 53,220 | 75,220 (0%) | 0% | 0 | Common Stock | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 1,892 | 26,559 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.76 per share. | 05 Mar 2021 | 460 | 26,099 (0%) | 0% | 110.8 | 50,950 | Common Stock, $0.01 par value |
| enVVeno Medical Corporation | Robert A. Berman | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 838,000 | 838,000 | - | - | Stock Option | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Sale of securities on an exchange or to another person at price $ 103.57 per share. | 16 Feb 2021 | 11,140 | 31,029 (0%) | 0% | 103.6 | 1,153,770 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Sale of securities on an exchange or to another person at price $ 103.52 per share. | 16 Feb 2021 | 6,362 | 24,667 (0%) | 0% | 103.5 | 658,594 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.11 per share. | 16 Feb 2021 | 5,270 | 42,169 (0%) | 0% | 65.1 | 343,130 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 5,270 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.92 per share. | 16 Feb 2021 | 4,160 | 36,899 (0%) | 0% | 78.9 | 328,307 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 4,160 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.39 per share. | 16 Feb 2021 | 1,710 | 32,739 (0%) | 0% | 71.4 | 122,077 | Common Stock, $0.01 par value |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 1,710 | 0 | - | - | Employee Stock Option (right to buy) | |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Dec 2020 | 375,000 | 2,940,104 (13%) | 1% | - | Common Stock | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2020 | 1,880 | 1,880 | - | - | Restricted Stock Units | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2020 | 1,640 | 31,260 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2020 | 1,640 | 0 | - | - | Restricted Stock Units | |
| Cullen Frost Bankers Inc. | Robert A. Berman | Group Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.14 per share. | 25 Oct 2020 | 399 | 30,861 (0%) | 0% | 72.1 | 28,784 | Common Stock, $0.01 par value |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 16 Sep 2020 | 2,725,836 | 22,000 (0%) | 12% | - | Common Stock | |
| Rekor Systems Inc | Robert A. Berman | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.57 per share. | 05 Aug 2020 | 2,725,836 | 2,747,836 (12%) | 12% | 2.6 | 7,005,399 | Common Stock |
| enVVeno Medical Corporation | Robert A. Berman | CEO | Other type of transaction at price $ 0.00 per share. | 18 Jul 2020 | 1,080,207 | 0 | - | - | Stock Option | |
| enVVeno Medical Corporation | Robert A. Berman | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2020 | 1,080,207 | 1,080,207 | - | - | Stock Option | |
| enVVeno Medical Corporation | Robert A. Berman | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2020 | 1,000,000 | 1,000,000 | - | - | Stock Option |